Government ❯ Public Health

Pandemic Response

COVID-19 Covid-19 Mask Procurement COVID-19 Measures PPE Procurement COVID-19 Regulations Covid-19 Management COVID-19 Testing Monitoring and Tracking Funding Stockpiles Elderly Care Policies Lockdown Policies Nursing Homes Elderly Care Healthcare Oversight Vaccine Development Economic Measures Policy Analysis Evaluation Vaccination Policies Resource Allocation PPE Supply Chain Personal Protective Equipment PPE Supply Vaccine Distribution Lockdown Measures Contract Management Laboratory Facilities Vaccine Procurement International Cooperation COVID-19 Management Medical Equipment Exchange Political Accountability Covid-19 Measures Health Guidelines

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Approved by both companies’ boards, the all-stock acquisition is slated to close in 2025 pending regulatory approval.